LEVY Health

🚀 We’re #hiring! Join LEVY Health as a Patient Support Coordinator 💡 Are you passionate about women’s health and helping patients navigate their fertility journey? We’re looking for a bilingual (English & Spanish) Patient Support Coordinator to support patients and healthcare providers using LEVY Health’s innovative software. 💼 Part-time | Remote | US-based 🔹 Provide personalized support to patients navigating the LEVY Fertility Code 🔹 Assist with scheduling, patient communications & inquiries 🔹 Work closely with healthcare providers & customer success teams to enhance patient experience 🔹 Fluent #Spanish & #English required 📍 Competitive salary, benefits, and flexible remote work! 👉 Apply now: Patient Support Coordinator | Remote | Part-time 🔗 Full job description in the comments At LEVY Health, we believe in equal opportunities and diverse teams. If you’re excited about making a difference, we’d love to hear from you! 🧡 #Hiring #CustomerSuccess #CustomerCare #WomensHealth #RemoteJobs #LEVYHealth

🚨 New research highlights gender disparities in surgical reimbursement! 🚨 Gender bias in healthcare doesn’t just impact patient care: It’s built into the way medical procedures are valued and reimbursed. A new study in the Journal of Women’s Health shows that procedures performed on male patients are consistently reimbursed at higher rates than those for female patients, and this gap hasn’t improved in 20 years. 📊 Key findings: 🔹 30% higher RVUs → Procedures on male patients are assigned higher relative value units (RVUs) compared to those on female patients. 🔹 $75.73 more reimbursement → Male-specific procedures are reimbursed with more money than female-specific procedures. 🔹 20 years → No meaningful improvement in reimbursement disparities. 💡 Why does this matter? Relative Value Units (RVUs) determine how much physicians are paid for different procedures. This large-scale study, analyzing 110 gender-specific surgical procedures over two decades, confirms what many have suspected: procedures on female patients are systematically undervalued. It’s time to close the gap and ensure fair reimbursement for all. Link to study in comments below ⬇️

💜 This International Women's Day, let’s celebrate women – and work toward a future where they no longer have to fight for their #health. For too long, women’s symptoms have been dismissed, their pain ignored, and their diagnoses delayed. The result? A silent health #crisis: 🚨 70% of PCOS cases go undiagnosed – affecting fertility, metabolism, and long-term well-being. ⏳ 10 years—the time it takes, on average, to diagnose endometriosis. A decade of pain. A decade too long. 🦋 1 in 8 women will develop a thyroid disorder, yet 60% go undiagnosed – leading to chronic fatigue, depression, and serious health risks. But change is happening. More women are speaking up, demanding #answers, and pushing for the care they deserve. More research is being done. More innovations– like what we’re building at LEVY Health – are closing the gender health gap, ensuring early detection and evidence-based treatments. ✨ The future of women’s health is in our hands. ✨ 💜 This International Women’s Day, let’s do more than acknowledge the problem – let’s be part of the solution. Small actions can create big change. 💡 #Encourage open conversations about women’s health – whether in your workplace, community, or among friends. 🗣️ #Talk openly about diagnoses and treatment experiences – breaking the silence can help others feel less alone and empower them to seek care. 📚 #Share reliable resources so more people have access to the information they need. (Check out our LEVY Biomarker & Diagnosis Lexicon and Blog 🤫). 🩺 #Support initiatives that advocate for better healthcare access and research for women. ⏳ #Prioritize your Health – If you’ve been putting off an important check-up, consider making that appointment today. Early detection saves lives. Because when women get the healthcare they deserve, they thrive. And when women thrive, society thrives. 💙 Together, we can create a world where no woman is left waiting for answers. #InternationalWomensDay #IWD2025 #HealthEquity #EndTheWait #LEVYHealth #FertilityCareForAll #TheFutureIsFemale

Imagine an open-source data hub for research in reproductive health. Pharma companies, fertility clinics, nonprofits, startups all sharing their data. Would you contribute your data, and how would you use it? We talked to Carmen Messerlian, Founder of the The Vie Institute for Generational Health, who is building this data hub. Check out the interview in the comments! #IVF #Fertility #Harvard #reproductivehealth #healthdata #research

#Infertility doesn’t discriminate, but access to care does. Black women are nearly twice as likely to experience infertility as white women - yet they are far less likely to receive treatment. Research shows that while 15% of Black women report infertility, only 8% seek medical help, compared to 15% of white women. The barriers? Systemic bias, financial constraints, medical mistrust, and lack of culturally competent care. How can we change this? ✔️ Expand #insurance coverage for fertility treatments. ✔️ Address medical bias through provider education and patient advocacy. ✔️ Increase Black representation in fertility medicine. ✔️ Break the stigma through community conversations and #education. At LEVY Health, we believe in making fertility care accessible, inclusive, and equitable for everyone. Our clinical decision support software helps providers diagnose infertility faster, reduce medical bias, and create personalized care plans - ensuring that no one is left behind due to systemic inequities. The conversation on reproductive justice needs to continue! #InfertilityAwareness #BlackWomensHealth #ReproductiveJustice #HealthEquity #FertilityCareForAll

🗞️🔊: "The Father of IVF", President Donald Trump, has just announced an Executive Order to Expand Access to In-Vitro-Fertilization! This is a bold step that has the potential to help thousands of couples—costs for assisted reproductive treatments are staggering and continue to be the number one reason, why couples don't start or stop their fertility journey. We are excited for this announcement, as it would increase access to reproductive care. Though, the industry isn't ready for increasing demand (yet). The number of reproductive endocrinologists (REIs) and IVF labs won’t double overnight. With roughly 1,500 REIs in the United States, and the same number of new joiners vs. leavers (roughly 50 each year), clinics need to innovate and re-invent their processes - which takes time & trust. At LEVY Health, we’re here to support clinics in coping with increasing demand. We take over the entire fertility work-up: screening, diagnosing and triaging patients prior to their first appointment. Patients are ready for treatment when they see their REI for the first time. This helps freeing up an REIs’ time, enables clinics to take on more treatments, while patient's are empowered to make informed decisions. Let’s make this happen together! #FertilityCare #IVF #Innovation

🌟 Welcome to the team, Pedro! Our tech team has been working hard! Each clinic we partner with is unique, so we tailor our platform to their specific needs and address technical challenges. To keep up with our growing number of clinics, we’re excited to welcome a new software engineer to the team! Pedro, we’re thrilled to have you on board! 🚀 His best health tip? "Take care of your body and mind." Prioritizing both helps you stay healthy, balanced, and perform at your best. 💡 We couldn’t agree more! 💙 #WelcomeToTheTeam #HealthTech #GrowingTeam

Better screening practices for #insulin resistance in #PCOS patients needed? A recent study by Liang et al., published in Fertility & Sterility (Jan 2025), shows a linear relationship between BMI and ART outcomes in women with #infertility, PCOS, and insulin resistance (HOMA-IR ≥ 2.69). The #findings are significant: For every 1 kg/m² increase in BMI: ➡️ Embryo implantation rates drop by 2% ➡️ Positive pregnancy test rates decrease by 11% ➡️ Clinical and ongoing pregnancy rates fall by 9% While there is already substantial research on obesity and reproductive outcomes, this study is specifically focuses on women with both PCOS and insulin resistance, shedding light on the compounded effects of metabolic health in this specific population. 👩⚕️ As our Chief Medical Advisor Dr. Esther Chung points out, this research underscores the need for better screening practices for insulin resistance in PCOS patients. Current REI protocols often rely on HbA1c to screen for diabetes, but more comprehensive methods—like calculating HOMA-IR (fasting insulin and glucose) or a 2-hour GTT with insulin—are underutilized. Understanding the distinction between insulin resistance and prediabetes could make a critical difference in tailoring treatment. At LEVY Health, we support this comprehensive approach by including fasting glucose testing as part of our fertility workup, ensuring providers have the information they need to guide patients effectively. #Fertility #PCOS #ReproductiveHealth #WomensHealth #WeightManagement #BMI #InsulinResistance

#ESHRE & #ASRM just published a new Guideline on Premature Ovarian Insufficiency (POI). 3 Key Takeaways & Thoughts: 💡 POI is more common than we thought. New data suggest a 3.5% prevalence, higher than the long-standing 1% estimate. Our own data have never aligned with the 1%, so we're glad to see this being recognized. 💡 Weak recommendations. Most diagnostic and treatment recommendations in this guideline are weak with only 1-2 points out of 4. That's not because the experts working on this guideline (Thank you to you all!) didn't do a good job. It is because high-quality research is still missing, and because AMH research was pretty much a mess for a long time. It’s disappointing that such a critical topic affecting so many women remains underfunded and understudied. 💡 AMH is undervalued in diagnostics. The guideline states: “Anti-Müllerian hormone (AMH) should not be used as the primary diagnostic test for POI.” (Strength of recommendation: Weak. No surprise there.) FSH is actually preferred in diagnostics. I understand that the shift from manual to automated AMH assays and new trajectories makes interpretation more complex, but in my opinion, AMH has a bigger potential here! We need better studies that take these differences of AMH assays into consideration to show that AMH is a great biomarker for identifying women at risk for POI before ovarian reserve is critically low. This is the approach we take at LEVY Health: We use age- and assay-specific AMH percentiles, adjusted for hormonal contraception, to predict POI risk years in advance. Because our goal isn’t to tell a 38-year-old that she has POI—it’s to tell a 32-year-old that she’s at high risk for POI at 38. That’s when action is still possible. Let’s push for better research, diagnostics, and proactive care in reproductive health. Women deserve it.   #POI #ReproductiveHealth #Fertility

📢 First #study to report an association between DFI and preeclampsia A recent Fertility and Sterility study (Jan 2025) explored the impact of sperm #DNA fragmentation (#DFI) on pregnancy health, with key findings: ➡️ Higher Risk of Preterm Birth: Elevated sperm DFI (DFI level of ≥20%) was associated with an increased risk of preterm birth (PTB), underscoring the role of paternal health in pregnancy outcomes. ➡️ Link to Preeclampsia: The study also found a connection between higher DFI (DFI level of ≥10%) and preeclampsia in IVF pregnancies, suggesting that compromised sperm DNA may affect placental development. ➡️ ICSI vs. IVF: Interestingly, this association wasn’t seen in ICSI pregnancies, hinting that ICSI might help bypass some of the challenges linked to sperm DNA fragmentation. "There has been a lot of interest in testing for sperm DNA fragmentation and understanding the impact of high DFI on reproductive outcomes. In my current practice, I check DFI in patients with a history of poor IVF outcomes related to embryo development or in those with unexplained recurrent pregnancy loss," says Dr. Esther Chung, Chief Medical Advisor at LEVY Health. The hypothesis regarding preeclampsia is that abnormal sperm DNA may lead to impaired placentation, contributing to the pathophysiology of preeclampsia. Additionally, sperm DNA fragmentation (SDF) is often linked to oxidative stress, which is also implicated in the development of preeclampsia. "I'm curious to better understand to what extent ICSI can help mitigate the effects of sperm DNA fragmentation," says Esther Chung. "Could high sperm DNA fragmentation become another male-factor indication for ICSI? What role might devices like Zymot or TESE play in these cases? In the future, will sperm DNA fragmentation testing become a standard part of the male infertility workup?" What’s your take? Have you been testing for DFI in your practice, and what have you observed? We’d love to hear your insights! 📚 Link to study in comments below #FertilityResearch #IVF #ICSI #ReproductiveHealth #SpermDNA